Eric Chetaille

891 total citations
18 papers, 294 citations indexed

About

Eric Chetaille is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric Chetaille has authored 18 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric Chetaille's work include Burn Injury Management and Outcomes (3 papers), Estrogen and related hormone effects (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Eric Chetaille is often cited by papers focused on Burn Injury Management and Outcomes (3 papers), Estrogen and related hormone effects (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Eric Chetaille collaborates with scholars based in France, Spain and Belgium. Eric Chetaille's co-authors include Bernard Marsigny, Emmanuel Cauchy, Mireille Lefèvre, Michel Andréjak, Guillaume Decocq, Martine Malissard, Noureddine Loukili, Valérie Gras‐Champel, Nathalie Corvaı̈a and Alain Beck and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Eric Chetaille

18 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Chetaille France 8 134 48 46 45 40 18 294
G. Corbetta Italy 10 75 0.6× 12 0.3× 11 0.2× 42 0.9× 6 0.1× 22 355
Gregory Rushing United States 9 89 0.7× 16 0.3× 14 0.3× 4 0.1× 23 0.6× 27 344
E. Ritz Germany 12 45 0.3× 12 0.3× 36 0.8× 20 0.4× 4 0.1× 29 329
Marvin Balaan United States 9 36 0.3× 40 0.8× 4 0.1× 13 0.3× 14 0.3× 31 379
Sushan Gupta United States 9 41 0.3× 68 1.4× 11 0.2× 17 0.4× 16 0.4× 24 321
C L Fields United States 10 60 0.4× 5 0.1× 24 0.5× 16 0.4× 47 1.2× 29 329
Ahmed Abdelaziz Egypt 10 83 0.6× 6 0.1× 9 0.2× 10 0.2× 17 0.4× 65 329
Giulia Bersani Italy 10 65 0.5× 16 0.3× 5 0.1× 17 0.4× 6 0.1× 33 330
Ann A. Browder United States 10 74 0.6× 5 0.1× 12 0.3× 40 0.9× 57 1.4× 20 331
Syed G Rizvi Oman 12 60 0.4× 35 0.7× 47 1.0× 12 0.3× 11 0.3× 27 358

Countries citing papers authored by Eric Chetaille

Since Specialization
Citations

This map shows the geographic impact of Eric Chetaille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Chetaille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Chetaille more than expected).

Fields of papers citing papers by Eric Chetaille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Chetaille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Chetaille. The network helps show where Eric Chetaille may publish in the future.

Co-authorship network of co-authors of Eric Chetaille

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Chetaille. A scholar is included among the top collaborators of Eric Chetaille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Chetaille. Eric Chetaille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Melero, Ignacio, Carlos Gomez‐Roca, Pierre Ferré, et al.. (2020). 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. SHILAP Revista de lepidopterología. A193.2–A194. 5 indexed citations
2.
Cruzalegui, Francisco, Noureddine Loukili, Olivier Delfour, et al.. (2020). Abstract 3372: VISTA interaction with PSGL1, a likely VISTA receptor in tumors, is effectively disrupted by K0401-020 anti-VISTA antibody. Cancer Research. 80(16_Supplement). 3372–3372. 6 indexed citations
3.
Broussas, Matthieu, Noureddine Loukili, Alain Robert, et al.. (2019). Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors. Molecular Cancer Therapeutics. 19(1). 168–177. 22 indexed citations
5.
Loukili, Noureddine, Alain Robert, Martine Malissard, et al.. (2018). Abstract 815: New approach for old target: W0101 antibody drug conjugate effectively inhibits tumor growth in preclinical models of IGF-1R overexpressing solid tumors. Cancer Research. 78(13_Supplement). 815–815. 3 indexed citations
6.
Pautier, Patricia, Ignace Vergote, Florence Joly, et al.. (2016). A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. International Journal of Gynecological Cancer. 27(2). 258–266. 32 indexed citations
7.
Cauchy, Emmanuel, et al.. (2016). Iloprost With and Without rt-PA: Treatment of 131 Cases of Severe Frostbite. Wilderness and Environmental Medicine. 27(3). 432–432. 1 indexed citations
8.
Parra‐Guillén, Zinnia P., et al.. (2014). Population Pharmacokinetic Modelling of Irosustat in Postmenopausal Women with Oestrogen-Receptor Positive Breast Cancer Incorporating Non-Linear Red Blood Cell Uptake. Pharmaceutical Research. 32(4). 1493–1504. 7 indexed citations
10.
Denmeade, S., et al.. (2011). 7047 POSTER A Phase I Pharmacodynamic Dose Escalation Study of Steroid Sulphatase Inhibitor Irosustat in Patients With Prostate Cancer. European Journal of Cancer. 47. S499–S499. 5 indexed citations
11.
Cauchy, Emmanuel, et al.. (2001). Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme. Wilderness and Environmental Medicine. 12(4). 248–255. 79 indexed citations
12.
Cauchy, Emmanuel, et al.. (2000). The role of bone scanning in severe frostbite of the extremities: a retrospective study of 88 cases. European Journal of Nuclear Medicine and Molecular Imaging. 27(5). 497–502. 38 indexed citations
14.
Chetaille, Eric, Richard Delcenserie, T. Yzet, et al.. (1998). [Minocycline involvement in two cases of acute pancreatitis].. PubMed. 22(5). 555–6. 6 indexed citations
15.
Chetaille, Eric, L Hary, B. De Cagny, et al.. (1998). [Convulsive crisis associated with an overdose of cefepime].. PubMed. 53(2). 167–8. 10 indexed citations
16.
Masmoudi, Kamel, et al.. (1996). [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].. PubMed. 50(5). 451–4. 6 indexed citations
17.
Andréjak, Michel, Guillaume Decocq, Eric Chetaille, et al.. (1996). [Antibiotic-associated pseudomembranous colitis: retrospective study of 48 cases diagnosed by colonoscopy].. PubMed. 51(1). 81–6. 3 indexed citations
18.
Chetaille, Eric, et al.. (1995). [Convulsions associated with the administration of excessive dose of ceftazidime in patients with renal failure].. PubMed. 49(5). 435–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026